OptoLight Vision
Eye Implants for Patients with Retinal Diseases
Health Tech & Life Sciences
Non Active, Aug 2023 ceased to operate
Company Overview
Snapshot
Founded in January 2006 by Isaac Lipshitz and Yariv Lipshitz, OptoLight Vision operated with 1–10 employees. The company ceased operations in August 2023.
Business overview
OptoLight Vision specializes in the development of intraocular telescopic eye implants designed to treat patients suffering from age-related macular degeneration (AMD) and other retinal diseases. The company's core technology focuses on improving both near and distance vision for individuals affected by either wet or dry AMD, operating within the Health Tech & Life Sciences sector, specifically targeting medical devices and medical treatment & therapeutics.
Company Intelligence Q&A
- What is OptoLight Vision's primary focus?
- OptoLight Vision develops intraocular telescopic eye implants for patients with age-related macular degeneration (AMD) and other retinal diseases, aiming to improve both near and distance vision.
- When was OptoLight Vision founded?
- OptoLight Vision was founded in January 2006.
- Who are the founders of OptoLight Vision?
- OptoLight Vision was co-founded by Isaac Lipshitz and Yariv Lipshitz.
- What is the operational status of OptoLight Vision?
- OptoLight Vision ceased operations in August 2023.
- What products does OptoLight Vision offer?
- OptoLight Vision offers products named OriLens and LMI.